We will discuss the key mechanisms of Lico-A that confer neuroprotection in AD, including PTP1B inhibition, anti-inflammatory effects, antioxidant properties, amyloid reduction, and acetylcholinesterase inhibition. Here, PTPN1 is linked to Alzheimer disease.